# FDA Inspection 1148403 - Hisun Pharmaceutical Hangzhou Co., Ltd - July 20, 2021

Source: https://www.keypedia.com/records/fda_inspections/hisun-pharmaceutical-hangzhou-co-ltd/8dc04bea-d5ae-48a6-ab27-077fae52fc45
Source feed: FDA_Inspections

> FDA Inspection 1148403 for Hisun Pharmaceutical Hangzhou Co., Ltd on July 20, 2021. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1148403
- Company Name: Hisun Pharmaceutical Hangzhou Co., Ltd
- Inspection Date: 2021-07-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1236569 - 2024-03-26](https://www.keypedia.com/records/fda_inspections/hisun-pharmaceutical-hangzhou-co-ltd/6e6d5609-62b4-4469-8501-7731475cbdb3)
- [FDA Inspection 1148403 - 2021-07-20](https://www.keypedia.com/records/fda_inspections/hisun-pharmaceutical-hangzhou-co-ltd/1d66e127-1d15-4c39-9f82-1c6338b80ee9)
- [FDA Inspection 1079698 - 2019-01-25](https://www.keypedia.com/records/fda_inspections/hisun-pharmaceutical-hangzhou-co-ltd/082e967a-9a73-408b-b106-b8036eb348bd)
- [FDA Inspection 1044032 - 2018-03-06](https://www.keypedia.com/records/fda_inspections/hisun-pharmaceutical-hangzhou-co-ltd/923ff231-ab64-4b74-ac2e-b134aa4c2b2a)
- [FDA Inspection 992914 - 2016-10-27](https://www.keypedia.com/records/fda_inspections/hisun-pharmaceutical-hangzhou-co-ltd/4b1e8bb4-79fd-4796-a597-a1d2f3269047)

Company: https://www.keypedia.com/companies/hisun-pharmaceutical-hangzhou-co-ltd/08054db1-b8fe-4c18-8ee5-e6098cb2e427

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c